1-3 of 3
Karen Tang
Close
Sort by
Journal Articles

Treatment with IMR-687, a Highly Selective PDE9 Inhibitor, Increases HbF and Reduces VOCs in Adults with Sickle Cell Disease in a Long-Term, Phase 2a, Open-Label Extension Study

Biree Andemariam, Timothy Mant, Perla Eleftheriou, Sanne Lugthart, Lanetta Bronté-Hall, Filipa Barroso, Gershwin Blyden, James Mason, Constance M Barysauskas, Joseph Yen, Karen Tang, Rahul Ballal, Kenneth Attie
Journal: Blood
Blood (2021) 138 (Supplement 1): 2046.
https://doi.org/10.1182/blood-2021-149536
Published: 2021
Journal Articles

Predictors of Vascular Events and Disease Transformation in Chinese Patients with Myeloproliferative Neoplasms during Long-Term Follow-up

Garret MK Leung, Jamilla Li, MBBS, MRCP, Karen Tang, MBBS, MRCP, Rita Yim, Ho-Wan Ip, MBBS,FRCPA, Jason Chi Chiu So, FRCPath,MBBS, Rock Y.Y. Leung, Clarence C.K. Lam, Yok-Lam Kwong, Harinder Gill, MDFRCP,MBBS,MRCP
Journal: Blood
Blood (2017) 130 (Supplement 1): 5273.
https://doi.org/10.1182/blood.V130.Suppl_1.5273.5273
Published: 2017
Journal Articles

Next-Generation Sequencing with a 54-Gene Panel Identifies Unique Mutational Profile and Prognostic Markers in Chinese Patients with Myelofibrosis

Harinder Gill, MDFRCP,MBBS,MRCP, Ho-Wan Ip, MBBS,FRCPA, Rita Yim, Tommy W.F. Tang, Herbert H Pang, Paul Lee, Garret MK Leung, Jamilla Li, MBBS, MRCP, Karen Tang, MBBS, MRCP, Jason Chi Chiu So, FRCPath,MBBS, Rock Y.Y. Leung, Jun Li, PhD, Gianni Panagioutou, Clarence C.K. Lam, Yok-Lam Kwong
Journal: Blood
Blood (2017) 130 (Supplement 1): 1638.
https://doi.org/10.1182/blood.V130.Suppl_1.1638.1638
Published: 2017